New KIR-CAR T cell therapy shows promise in multiple solid cancers
The first Phase I clinical trial uses a CAR T cell therapy inspired by natural killer (NK) cells, designed to reduce T cell exhaustion.
The first Phase I clinical trial uses a CAR T cell therapy inspired by natural killer (NK) cells, designed to reduce T cell exhaustion.